Associated Papers
Calcilytic NPSP795 Increases Plasma Calcium and PTH in an Autosomal Dominant Hypocalcemia Type 1 Mouse Model.
Hannan FM et al.
Jbmr Plus, 2020
International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.
Leach K et al.
Pharmacological Reviews, 2020
Activating Mutations of the G-protein Subunit α 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2.
Gorvin CM et al.
The Journal of Clinical Endocrinology and Metabolism, 2020
Knockin mouse with mutant Gα11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors.
Roszko KL et al.
Jci Insight, 2017
Gα11 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy.
Gorvin CM et al.
Jci Insight, 2017
Select a paper to view details